Scholars Central

Review articlePublished 22 Jul 2016

Bicuspid aortic valves and TAVI: is it still an exclusion criterion? State of the art and open issues

Authors: P Spatuzza, N Ruparelia & A Latib

Interventional Cardiology

Volume 7 · Issue 4 · Pages 379–386

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bicuspid aortic valve (BAV) is the most common congenital valvular disease, and is found in approximately 22% of all patients presenting with symptomatic severe aortic stenosis who are deemed high-risk for surgery. While BAV has historically been considered a relative contraindication to transcatheter aortic valve implantation, technical improvements in addition to greater operator confidence and experience has resulted in an increased number of percutaneous valve implantations in this patient group. Areas of uncertainty remain, but data from the literature suggests that the procedure can be safely performed in the setting of BAV, with results comparable to tricuspid aortic valve patients, at the expense of higher rates of shortterm complications and postprocedural aortic regurgitation.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Interventional Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInterventional Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “P Spatuzza”
  • BylineArticles whose byline prints “N Ruparelia & A Latib”